sch 51048 has been researched along with triazoles in 7 studies
| Studies (sch 51048) | Trials (sch 51048) | Recent Studies (post-2010) (sch 51048) | Studies (triazoles) | Trials (triazoles) | Recent Studies (post-2010) (triazoles) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 25,808 | 2,252 | 13,501 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allendoerfer, R; Graybill, JR; Loebenberg, D; Rinaldi, MG | 1 |
| Clemons, KV; Homola, ME; Stevens, DA | 1 |
| Picard, M; Sugar, AM | 1 |
| Anaissie, EJ; Dignani, MC; Karyotakis, NC | 1 |
| Blundell, P; Cacciapuoti, A; Girijavallabhan, VM; Guzik, H; Loebenberg, D; Lovey, RG; Parmegiani, RM; Saksena, AK | 1 |
| Bennett, F; Cacciapuoti, A; Ganguly, AK; Girijavallabhan, VM; Hare, RS; Jao, E; Liu, YT; Loebenberg, D; Lovey, RG; Menzel, F; Moss, E; Nomeir, A; Patel, NM; Pike, R; Pinto, P; Saksena, AK; Wang, H | 1 |
| Bartner, P; Bennett, F; Cacciapuoti, A; Ganguly, AK; Girijavallabhan, V; Hare, R; Heimark, L; Hilbert, M; Korfmacher, W; Kumari, P; Lin, CC; Liu, YT; Loebenberg, D; Lovey, R; McNamara, P; Miller, G; Nomeir, AA; Pickett, C; Pike, R; Pramanik, BN; Saksena, A; Veals, J; Wang, H | 1 |
7 other study(ies) available for sch 51048 and triazoles
| Article | Year |
|---|---|
Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Evaluation; Female; Itraconazole; Lung Diseases, Fungal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Survival Rate; Triazoles | 1995 |
Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Female; Fluconazole; Half-Life; Itraconazole; Mice; Microbial Sensitivity Tests; Triazoles | 1995 |
Treatment of murine pulmonary blastomycosis with SCH 51048, a broad-spectrum triazole antifungal agent.
Topics: Animals; Antifungal Agents; Blastomycosis; Lung Diseases, Fungal; Male; Mice; Mice, Inbred ICR; Triazoles | 1995 |
SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred Strains; Neutropenia; Triazoles | 1995 |
Synthesis and antifungal activity of the 2,2,5-tetrahydrofuran regioisomers of SCH 51048.
Topics: Antifungal Agents; Benzene; Binding Sites; Furans; In Vitro Techniques; Microbial Sensitivity Tests; Oxygen; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2002 |
Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5].
Topics: Alcohols; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Haplorhini; Humans; Immunosuppressive Agents; Mice; Models, Chemical; Time Factors; Triazoles | 2006 |
Posaconazole (Noxafil, SCH 56592), a new azole antifungal drug, was a discovery based on the isolation and mass spectral characterization of a circulating metabolite of an earlier lead (SCH 51048).
Topics: Animals; Antifungal Agents; Chromatography, High Pressure Liquid; Dogs; Drug Design; Macaca fascicularis; Male; Mass Spectrometry; Mice; Mice, Inbred Strains; Rabbits; Triazoles | 2008 |